MiR-1246 targets telomeric repeat binding factor 2 interacting protein (TERF2IP) and markedly promotes M2 macrophage polarization by activating the STAT3 pathway and inhibiting the NF-κB pathway, and ultimately leading to tumor proliferation, migration and invasion [81]. Here, TERF2IP is linked to neoplasm.